News Focus
News Focus
icon url

jq1234

02/16/11 1:09 PM

#114889 RE: DewDiligence #114885

It'll be tough near term. Eventually it might, depends on long term safety profile and competition. Dosing schedule is convenient. It also has this question about pricing with Campath.